'Groundbreaking' gene-editing therapy receives ethical thumbs up

A new gene-editing therapy designed to help treat patients suffering from sickle cell disease has been endorsed by the National Catholic Bioethics Center.

Related Keywords

United States ,Americans ,Peter Pinedo ,Tracy Sabol ,Joseph Meaney ,National Catholic Bioethics Center ,Vertex Pharmaceuticals ,Donum Vitae ,African Americans ,Americas ,Bioethics ,Catholic News ,Rispr ,Biomedical Ethics ,